2nd Line Treatment With Pemetrexed and Sorafenib for Recurrent or Metastatic Triple Negative Breast Cancer
Clinical trial NCT02624700 · TERMINATED
Trial details
- NCT number
- NCT02624700
- Sponsor
- Virginia Commonwealth University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-28
- Primary completion
- 2019-07-10
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.